Metagenomic next-generation sequencing (mNGS) is a novel tool for identifying microbial DNA and/or RNA in blood and other clinical specimens. In the face of increasingly complex patients and an ever-growing list of known potential pathogens, mNGS has been proposed as a breakthrough tool for unbiased pathogen identification. Studies have begun to explore the clinical applicability of mNGS in a variety of settings, including endocarditis, pneumonia, febrile neutropenia, osteoarticular infections, and returning travelers. The real-world impact of mNGS has also been assessed through retrospective studies, documenting varying degrees of success and limitations. In this review, we will explore current highlights of the clinical mNGS literature, with a focus on pediatric data where available. We aim to provide the reader with a deeper understanding of the strengths and weaknesses of mNGS and to provide direction toward areas requiring further research.
CITATION STYLE
Edward, P., & Handel, A. S. (2021). Metagenomic Next-Generation Sequencing for Infectious Disease Diagnosis: A Review of the Literature with a Focus on Pediatrics. Journal of the Pediatric Infectious Diseases Society, 10, S71–S77. https://doi.org/10.1093/jpids/piab104
Mendeley helps you to discover research relevant for your work.